Status of ALS Treatment, Insights into Therapeutic Challenges and Dilemmas

Area of Science:

• Neuroscience
• Pharmacology
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease with significant heterogeneity.
• Current treatments like riluzole offer only modest survival benefits.
• Despite advances in understanding ALS, drug development remains challenging.

Purpose of the Study:

• To discuss challenges in drug development for ALS at conceptual, technological, and methodological levels.
• To address socioeconomic and ethical issues impacting patient access to new treatments.
• To provide an optimistic outlook on ALS therapeutic advancements.

Main Methods:

• This is an opinion review paper.
• It discusses conceptual, technological, and methodological challenges.
• It addresses socioeconomic and ethical considerations.

Main Results:

• Drug development for ALS is complex due to disease heterogeneity.
• Socioeconomic and ethical factors influence treatment accessibility.
• Recent approvals and gene therapies indicate progress.

Conclusions:

• Despite challenges, the outlook for ALS drug development is increasingly optimistic.
• Targeted gene therapies and new drug approvals represent significant advancements.
• Addressing multifaceted challenges is key to accelerating patient benefit.